Who is in your network?

Cannabis Testing market Share, Growth Analysis by 2035

The legalization and recent applications of cannabis for the treatment of certain medical conditions has led to the rise in demand for various cannabis-infused products.

These products need to be tested thoroughly, in order to maintain regulatory standards and ensure consumer safety. Following this, cannabis testing services are currently being used across several industries, including healthcare, chemical, cosmetic, agriculture and food. The financial opportunity within the cannabis testing market has been analyzed across the following segments:
 Type of Cannabis Tested
 Medical Cannabis
 Recreational / Adult-use Cannabis
 Type of Sample Tested
 Flowers
 Extracts
 Edibles
 Others
 Company Size
 Large
 Mid-sized
 Small
 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

The research also includes profiles of key players (listed below) engaged in the cannabis testing market; each profile features a brief overview of the company, details related to its financial information (if available), service portfolio, recent developments, and an informed future outlook.
 AccuScience Laboratories
 Anresco Labs
 CDX Analytics
 Coastal Analytical
 Eurofins Scientific
 EVIO Labs
 FoodChain ID
 LGC
 Medicine Creek Analytics
 SGS
 Tentamus

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape: Cannabis Testing Service Providers

5. Cannabis Testing Service Providers: Company Competitiveness Analysis

6. Cannabis Testing Service Providers: Company Profiles

7. Market Landscape: Medicinal Cannabis Testing Product Providers

8. Partnerships and Collaborations

9. Global Event Analysis

10. Cannabis Testing Services Market: Market Sizing and Opportunity Analysis

11. Concluding Remarks

12. Executive Insights

13. Appendix 1: Tabulated Data

14. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/cannabis-tes

Learn from experts: do you know about these emerging industry trends?
Top 5 Companies Developing Bispecific Antibodies
Top 10 Cell and Gene Therapy Companies

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Connect with our Roots Analysis Consulting team: For your custom research exclusive best-in-class quality projects

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#cannabistestingmarket#cannabistestingmarketsize #cannabistesting #cannabistestingmarket #marijuanatesting

Medical Device Coating market Professional Survey Report by 2035

The growing demand for complex medical devices has prompted developers to innovate and introduce biocompatible, high-performance medical device coatings that can meet the operational, clinical, and engineering requirements for these devices.

Presently, multiple types of medical device coating are available in the market to accommodate the multifunctionality of novel medical devices. A detailed medical coatings market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

 Type of Devices Coated
 Class I Medical Devices
 Class II Medical Devices
 Class III Medical Devices

 Type of Coating Material
 Polymer Coatings
 Metal Coatings
 Other Coatings

 Company Size
 Very Small
 Small
 Mid-sized
 Large
 Very Large

 Key Geographical Region
 North America
 Europe
 Asia
 Rest of the World

Key companies covered in the report
 Advanced Coating
 Biocoat
 Evonik
 Formacoat
 Harland Medical Systems
 Para-Coat Technologies
 Specialty Coating Systems
 SurModics
 TUA Systems

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Medical Device Coating Providers: Market Landscape

5. Company Competitiveness Analysis

6. Surface Modification Technologies and Coating Solutions: Market Landscape

7. Product Competitiveness Analysis

8. Medical Device Coating Providers: Company Profiles

9. Partnerships and Collaborations

10. Medical Coatings Providers: Pestle Analysis

11. Market Forecast

12. Concluding Remarks

13. Executive Insights

14. Appendix 1: Tabulated Data

15. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/medical-devi

Learn from experts: do you know about these emerging industry trends?
Adeno-Associated Viral Vectors: Unlocking the Future Opportunities
Modular Construction – Retrofitting Conventional Buildings

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#medicaldevicecoatingmarket #medicaldevicecoatingmarketsize #medicaldevicecoating #medicalcoatingsmarket #medicalcoatingcompanies

Deep Learning in Drug Discovery market Professional Survey Report by 2035

The traditional statistical tools and techniques available for medical data interpretation are known to be associated with challenges related to time and cost.

This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug discovery and diagnosis. In addition, recent investments made in this domain are likely to offer lucrative opportunities to companies offering deep learning technology / solutions within the healthcare industry. An elaborate valuation analysis of companies that are involved in the deep learning in drug discovery and diagnostics market, based on our proprietary, multi-variable dependent valuation model to estimate the current valuation / net worth of deep learning industry players.

The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:
 Therapeutic Area
 Oncological Disorders
 Infectious Diseases
 Neurological Disorders
 Immunological Disorders
 Endocrine Disorders
 Cardiovascular Disorders
 Respiratory Disorders
 Ophthalmic Disorders
 Musculoskeletal Disorders
 Inflammatory Disorders
 Other Disorders

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Rest of the World

The Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
 Aegicare
 Aiforia Technologies
 Ardigen
 Berg
 Google
 Huawei
 Merative
 Nference
 NVIDIA
 Owkin
 Phenomic AI
 Pixel AI

Table of Contents

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY

5. MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS

6. COMPANY PROFILES

7. PORTER’S FIVE FORCES ANALYSIS

8. CLINICAL TRIAL ANALYSIS

9. FUNDING AND INVESTMENT ANALYSIS

10. START-UP HEALTH INDEXING

11. COMPANY VALUATION ANALYSIS

12. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY

13. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS

14. DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS

15. CONCLUDING REMARKS

16. INTERVIEW TRANSCRIPTS

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/view_documen

Learn from experts: do you know about these emerging industry trends?
Key Trends in Non-Viral Transfection Market
Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

The traditional statistical tools and techniques available for medical data interpretation are known to be associated with challenges related to time and cost.

This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug discovery and diagnosis. In addition, recent investments made in this domain are likely to offer lucrative opportunities to companies offering deep learning technology / solutions within the healthcare industry. An elaborate valuation analysis of companies that are involved in the deep learning in drug discovery and diagnostics market, based on our proprietary, multi-variable dependent valuation model to estimate the current valuation / net worth of deep learning industry players.

The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:
 Therapeutic Area
 Oncological Disorders
 Infectious Diseases
 Neurological Disorders
 Immunological Disorders
 Endocrine Disorders
 Cardiovascular Disorders
 Respiratory Disorders
 Ophthalmic Disorders
 Musculoskeletal Disorders
 Inflammatory Disorders
 Other Disorders

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Rest of the World

The Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
 Aegicare
 Aiforia Technologies
 Ardigen
 Berg
 Google
 Huawei
 Merative
 Nference
 NVIDIA
 Owkin
 Phenomic AI
 Pixel AI

Table of Contents

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY

5. MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS

6. COMPANY PROFILES

7. PORTER’S FIVE FORCES ANALYSIS

8. CLINICAL TRIAL ANALYSIS

9. FUNDING AND INVESTMENT ANALYSIS

10. START-UP HEALTH INDEXING

11. COMPANY VALUATION ANALYSIS

12. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY

13. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS

14. DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS

15. CONCLUDING REMARKS

16. INTERVIEW TRANSCRIPTS

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/view_documen

Learn from experts: do you know about these emerging industry trends?
Key Trends in Non-Viral Transfection Market
Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#deeplearningindrugdiscoverymarket #deeplearningindrugdiscoverymarketsize #deeplearningindustry #deeplearningtrends #deeplearningcompanies

Cell Free Expression market Growth Analysis by 2035

Considering the benefits offered by cell free expression, including low cost of production, shortened production timelines and better control over the reaction environment, the adoption of cell free systems has increased over the years.

Driven by the ongoing pace of innovation and growing adoption of cell free systems in the production of biomolecules, the global cell free expression market is anticipated to grow at a healthy pace in the foreseen future.

The financial opportunity within the cell free market is analyzed across the following segments:

 Type of Cell Free System
 Crude Cell Lysate-based Systems
 Reconstituted Systems

 Type of Host Organism
 Microbial Cell Free Expression System
 Mammalian Cell Free Expression Systems
 Plant-based Cell Free Expression Systems
 Other Cell Free Expression Systems

 Type of Expression Method
 Coupled Transcription and Translation Method
 Translation Method

 End-User
 Pharmaceutical and Biotechnology Companies
 Academic and Research Institutes
 Other End-Users

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Rest of the World

The Cell Free Systems: Cell Free Expression Kits and Service Providers, 2023-2035 report features the following companies, which we identified to be key players in this domain:
 BioLinker
 biotechrabbit
 CellFree Sciences
 Creative Biolabs
 CUSABIO
 Daicel Arbor Biosciences
 LenioBio
 Promega
 Thermo Fisher Scientific
 Touchlight

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape: Cell Free Expression Service Providers

5. Market Landscape: Cell Free Expression Kits

6. Cell Free Expression Service Providers: Company Competitiveness Analysis

7. Cell Free Expression Kits: Product Competitiveness Analysis

8. Company Profiles: Cell Free Expression Service Providers

9. Company Profiles: Cell Free Expression Kit Providers

10. Partnerships And Collaborations

11. Funding And Investment Analysis

12. Patent Analysis

13. Market Forecast And Opportunity Analysis

16. Appendix 1: Tabulated Data

17. Appendix 2: List Of Companies And Organizations

For additional details, please visit https://www.rootsanalysis.com/....reports/cell-free-ex

Learn from experts: do you know about these emerging industry trends?
Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities
Investment Opportunities in Women’s Digital Health

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#cellfreeexpressionmarkettrends #cellfreeexpressionmarketgrowth #cellfreeproteinexpressionsystem #biomanufacturing #cellfreeexpressionsystem

Antibody Drug Conjugate market Growth Analysis and Forecast by 2035

The potential of antibody drug conjugates for the treatment of various disease indications, including cancer, is being slowly recognized in the pharmaceutical sector. Specifically, the success of these products can be attributed to their ability to effectively identify and eliminate diseased cells, along with low risk of side effects.

The financial opportunity within the antibody drug conjugate market has been analyzed across the following segments:

 Target Disease Indication
 Acute Lymphoblastic Leukemia
 Breast Cancer
 B-Cell Lymphoma
 Cervical Cancer
 Gastric Cancer
 Lung Cancer
 Multiple Myeloma
 Renal Cancer
 Other Target Disease Indications

 Therapeutic Area
 Hematological Cancer
 Solid Tumor

 Linker
 Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (Acbut)
 Maleimide
 Maleimidocaproyl
 Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate
 Tetrapeptide-Based Linker
 Valine-Alanine
 Valine-Citrulline
 Other Linkers

 Payload
 DM1
 DM4
 Duocarmycin
 Monomethyl auristatin E (MMAE)
 Monomethyl auristatin F (MMAF)
 Ozogamicin
 SG3199
 SN-38 / Irinotecan
 Other Payloads

 Target Antigen
 BCMA (TNFRSF17 / BCM)
 CD19
 CD22
 CD30
 CD79b
 CEACAM5
 HER-2 (ERBB2)
 Nectin 4
 Tissue factor
 TROP-2
 Other Target Antigen

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific and Rest of the World

The Antibody Drug Conjugate Market (7th Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
 ADC Therapeutics
 Astellas Pharma
 AstraZeneca
 Byondis
 Daiichi Sankyo
 Genentech
 Gilead Sciences
 ImmunoGen
 Pfizer
 RemeGen

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Target Competitiveness Analysis

6. Company and Drug Profiles

7. Clinical Trial Analysis

8. Key Opinion Leaders

9. Combination Therapies

10. Partnerships and Collaborations

11. Funding and Investment Analysis

12. Patent Analysis

13. Academic Grants Analysis

14. Key Commercialization Strategies

15. Promotional Analysis

16. Success Protocol Analysis

17. Novel Conjugation and Linker Technology Platforms

18. Assessment of Non-Clinical Data First in Human Dosing

19. Cost Price Analysis

20. Case Study 1: Contract Manufacturing of Antibody-Drug Conjugates

21. Case Study 2: Companion Diagnostics for Antibody-Drug Conjugate Therapeutics

22. SWOT Analysis

23. Market Sizing and Opportunity Analysis

24. Executive Insights

25. Conclusion

26. Appendix 1: Tabulated Data

27. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/view_documen

Learn from experts: do you know about these emerging industry trends?
Digital Therapies: The “Digital Pills” of current generation
Medical Device Coatings and Modification Technologies

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#antibodydrugconjugatemarketshare #antibodydrugconjugatemarkettrends #antibodydrugconjugates #adctherapeutics #antibodydrugconjugatecompanies